Although previous studies have confirmed that Rab5c was an oncogene that promote cancer progression or chemoresistance through various pathways [61–63], but our research first illustrate that Rab5c act as a target of Piezo1 and activate TGF-β signaling through in cancer cells. This evidence concerns the gene RAB5C and cancer.